NEW YORK (GenomeWeb News) — Agilent Technologies today said fiscal fourth-quarter revenues increased 6 percent as R&D spending fell 8 percent and profit surged 508 percent.
Total receipts for the three months ended Sept. 30 increased to $1.33 billion from $1.25 billion year over year.
Revenue for the company’s Bio-Analytical Measurement segment rose 9 percent to $418 million.
R&D spending decreased to $155 million from $168 million year over year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.